Proliferation of hepatocytes.
Hepatocyte proliferation may be controlled by reversible patterns of endocrine changes, monitored by the liver, involving known hormones and their receptors. A two-programme model of related interactions among nutrients, specific lipoproteins, and highly phosphorylated nucleotides is postulated. This hypothesis stems from in vitro studies of rat hepatocyte proliferation under chemically defined conditions and from in vivo studies using partially hepatectomized, hormone-infused, developing and lipotrope-deficient rats. Certain findings are discussed with regard to receptor systems which show negatively cooperative properties; to problems of proliferative specificity; and to novel approaches for defined studies of chemical hepatocarcinogenesis.
D015073:2-Acetylaminofluorene / Q000494:pharmacology; D000818:Animals; D001665:Binding Sites; D004247:DNA / Q000096:biosynthesis; D005934:Glucagon / Q000502:physiology; D005938:Glucocorticoids / Q000502:physiology; D066298:In Vitro Techniques; D007328:Insulin / Q000502:physiology; D008079:Lipoproteins, VLDL / Q000502:physiology; D008082:Lipotropic Agents / Q000502:physiology; D008099:Liver / Q000166:cytology*; D008113:Liver Neoplasms / Q000139:chemically induced; D008115:Liver Regeneration; D009711:Nucleotides / Q000378:metabolism; D051381:Rats; D011956:Receptors, Cell Surface
D005938:Glucocorticoids; D007328:Insulin; D008079:Lipoproteins, VLDL; D008082:Lipotropic Agents; D009711:Nucleotides; D011956:Receptors, Cell Surface; D004247:DNA; D005934:Glucagon; D015073:2-Acetylaminofluorene